2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Methamphetamine use and harms are rising rapidly. Management of patients with methamphetamine use disorder (MUD) and problematic methamphetamine use (PMU) is challenging, with no clearly established best approach; both psychosocial and pharmacologic interventions have been described. Furthermore, given the diversity of individuals that use methamphetamines, there is a need to assess evidence for treatments for subgroups including youths; gay, bisexual, and other men who have sex with men; individuals with mental health comorbidities; and individuals in correction services. Establishing awareness of the messages regarding treatment from recent clinical practice guidelines (CPG) in the field is also of value.

          The first study objective will be to establish a greater understanding of the methods, populations, and findings of controlled studies for psychosocial and pharmacologic treatments for MUD and PMU. Investigation of this information can help establish the potential for advanced syntheses of the evidence (such as network meta-analysis) to compare therapies for this condition and to identify gaps related to key populations where more primary research is needed. Summarizing the recommendations regarding treatment of MUD/PMU from recent CPGs and systematic reviews will be an important secondary objective.

          Methods

          A scoping review will be performed. Using the OVID platform, MEDLINE, Embase, PsycINFO, and relevant Cochrane databases from EBM Reviews will be searched (from databases’ inception onwards). Eligibility criteria will include individuals described as having MUD or PMU, with designs of interest including randomized trials, non-randomized trials, and controlled cohort studies with three or more months of follow-up; systematic reviews and CPGs will also be sought. Two reviewers (with support from automation tools) will independently screen all citations, full-text articles, and chart data. Different approaches to handling and summarizing the data will be implemented for each type of study design. Tables and graphics will be used to map evidence sources and identify evidence gaps.

          Discussion

          This research will enhance awareness of evidence addressing the effects of psychosocial and pharmacologic interventions for MUD/PMU overall and in sub-populations, both in terms of recent CPGs/reviews and primary studies; inspection of the latter will also help establish the feasibility of future syntheses to compare treatments, such as network meta-analysis.

          Systematic review protocol registration

          Open Science Framework ( https://osf.io/9wy8p)

          Related collections

          Most cited references70

          • Record: found
          • Abstract: not found
          • Article: not found

          Scoping studies: towards a methodological framework

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

            Systematic reviews should build on a protocol that describes the rationale, hypothesis, and planned methods of the review; few reviews report whether a protocol exists. Detailed, well-described protocols can facilitate the understanding and appraisal of the review methods, as well as the detection of modifications to methods and selective reporting in completed reviews. We describe the development of a reporting guideline, the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Protocols 2015 (PRISMA-P 2015). PRISMA-P consists of a 17-item checklist intended to facilitate the preparation and reporting of a robust protocol for the systematic review. Funders and those commissioning reviews might consider mandating the use of the checklist to facilitate the submission of relevant protocol information in funding applications. Similarly, peer reviewers and editors can use the guidance to gauge the completeness and transparency of a systematic review protocol submitted for publication in a journal or other medium.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

              The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.
                Bookmark

                Author and article information

                Contributors
                bhutton@ohri.ca
                Journal
                Syst Rev
                Syst Rev
                Systematic Reviews
                BioMed Central (London )
                2046-4053
                24 October 2020
                24 October 2020
                2020
                : 9
                : 245
                Affiliations
                [1 ]GRID grid.412687.e, ISNI 0000 0000 9606 5108, Center for Practice Changing Research, Ottawa Hospital Research Institute, , The Ottawa Hospital, General Campus, ; 501 Smyth Road, Box 201b, Ottawa, Ontario K1H 8 L6 Canada
                [2 ]GRID grid.414622.7, ISNI 0000 0001 1503 7525, Substance Use and Concurrent Disorders Program, , The Royal Ottawa Mental Health Centre, ; Ottawa, Ontario Canada
                [3 ]GRID grid.28046.38, ISNI 0000 0001 2182 2255, Department of Psychiatry, Faculty of Medicine, , University of Ottawa, ; Ottawa, Ontario Canada
                [4 ]GRID grid.28046.38, ISNI 0000 0001 2182 2255, Institute of Mental Health Research, , University of Ottawa, ; Ottawa, Ontario Canada
                [5 ]GRID grid.14709.3b, ISNI 0000 0004 1936 8649, Department of Psychology, , McGill University, ; Montreal, Quebec, Canada
                [6 ]GRID grid.28046.38, ISNI 0000 0001 2182 2255, Department of Family Medicine, Faculty of Medicine, , University of Ottawa, ; Ottawa, ON Canada
                [7 ]GRID grid.412687.e, ISNI 0000 0000 9606 5108, Division of Infectious Diseases, , The Ottawa Hospital, ; Ottawa, ON Canada
                [8 ]GRID grid.28046.38, ISNI 0000 0001 2182 2255, Faculty of Medicine, , University of Ottawa, ; Ottawa, ON Canada
                [9 ]GRID grid.155956.b, ISNI 0000 0000 8793 5925, Department of Pharmacy, , Centre for Addiction and Mental Health, ; Toronto, ON Canada
                [10 ]GRID grid.17063.33, ISNI 0000 0001 2157 2938, Leslie Dan Faculty of Pharmacy and Department of Psychiatry, , University of Toronto, ; Toronto, ON Canada
                [11 ]GRID grid.265695.b, Université du Quebec, ; Montreal, QC Canada
                [12 ]GRID grid.28046.38, ISNI 0000 0001 2182 2255, School of Epidemiology, Public Health and Preventive Medicine, , University of Ottawa, ; Ottawa, ON Canada
                [13 ]GRID grid.415400.4, ISNI 0000 0001 1505 2354, Public Health Ontario, ; Toronto, ON Canada
                [14 ]Canadian Center on Substance Use and Addiction, Ottawa, ON Canada
                [15 ]Max Ottawa, Ottawa, ON Canada
                Author information
                http://orcid.org/0000-0001-5662-8647
                Article
                1499
                10.1186/s13643-020-01499-z
                7585172
                33099314
                d3d296c9-fefc-4d56-884f-d1dc93445fca
                © The Author(s) 2020

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 3 July 2020
                : 4 October 2020
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100000024, Canadian Institutes of Health Research;
                Award ID: 201909MPU-428758-MPU-ADYP-170629
                Categories
                Protocol
                Custom metadata
                © The Author(s) 2020

                Public health
                methamphetamine,methamphetamine addiction,methamphetamine use disorder,psychosocial treatment,pharmacologic treatment,scoping review,knowledge synthesis

                Comments

                Comment on this article